| European Case Law Identifier: | ECLI:EP:BA:2013:T063709.20130320 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 20 March 2013 | ||||||||
| Case number: | T 0637/09 | ||||||||
| Application number: | 01900579.2 | ||||||||
| IPC class: | A61K 31/585 A61P 5/30 A61K 31/565 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Pharmaceutical combination of micronised drospirenone and an estrogen for hormone replacement therapy | ||||||||
| Applicant name: | Bayer Pharma Aktiengesellschaft | ||||||||
| Opponent name: | LABORATORIOS LEON FARMA S.A. | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Admission of submissions, documents and claim's requests (point 2) Main request and auxiliary requests I and II (added subject-matter) Auxiliary request IV: inventive step (no) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t090637eu1.html
Date retrieved: 17 May 2021